Announced Thu, 25 Jun · 17:02 IST
Trading window closed for quarter ended June 30 2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-9.4%1-day move
₹22.69
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-9.4-13.2-13.2-13.2-8.6-0.5-2.8———
Up moveDown movePending
AI summary
Brawn Biotech has closed its insider trading window for the quarter ending June 30, 2026. This is a routine compliance measure under SEBI insider trading rules. During this period, designated persons including directors, officers, and employees cannot buy or sell the companys shares. The window typically reopens 48 hours after the quarterly results are announced.
Likely market impact
Routine regulatory filing. No direct impact on stock price but signals upcoming quarterly results announcement.